Search
DarioHealth Corp
DRIOAdd to Watchlist
7.585USD
+0.255+3.48%
Close 08-14 16:00（ET）Quotes delayed by 15 min
55.36MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14The current earnings forecast score of DarioHealth Corp is 8.00, ranking 66 out of 201 in the Healthcare Equipment & Supplies industry. The average price target is 18.50, with a high of 25.00 and a low of 11.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
14.500
Target Price
+97.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
DarioHealth Corp
DRIO
4
Stryker Corp
SYK
30
Medtronic PLC
MDT
30
Dexcom Inc
DXCM
30
Abbott Laboratories
ABT
29
Zimmer Biomet Holdings Inc
ZBH
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is DarioHealth Corp's expected revenue for the next quarter?
DarioHealth Corp's expected revenue is 5.19M.
What is DarioHealth Corp's price target?
Analysts forecast that DarioHealth Corp's price target is USD 18.50, with the highest forecast at USD 25.00 and the lowest forecast at USD 11.00.
How have DarioHealth CorpDRIO's recent earnings per share performed?
The market expectation was USD -0.85, while DarioHealth CorpDRIO's earnings per share (EPS) for the previous quarter was USD -1.25. EPS for the next quarter is expected at USD -0.80.
What is the analyst rating for DarioHealth Corp?
Based on the ratings of DarioHealth Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.